Effect of High-Energy Milling on the Dissolution of Anti-HIV Drug Efavirenz in Different Solvents.

ACS Omega

Department of Civil, Environmental and Mechanical Engineering, University of Trento, Via Mesiano, 77, Trento 38123, Italy.

Published: May 2021

The anti-HIV drug efavirenz (EFV) displays low and variable bioavailability because of its poor aqueous solubility. Ball milling is a simple and cost-effective alternative to traditional micronization to improve the solubility and dissolution rate of EFV. A multibody dynamics model was employed to optimize the milling process parameters, while the motion of the balls in the mill jar was monitored . This led to a better understanding of the milling dynamics for efficient comminution and enhancement of EFV dissolution. The variability of results for different EFV batches was also considered. Depending on the EFV batch, there were intrinsic differences in how the milling affected the dissolution behavior and inhibition of HIV-1 infection. High-energy grinding is more effective on EFV materials containing an amorphous fraction; it helps to remove agglomeration and enhances dissolution. Polyvinylpyrrolidone (PVP) addition improves the dissolution by forming a hydrophilic layer on the EFV surface, thereby increasing the drug wettability. Polymorphism also affects the quality, dosage, and effectiveness of the drug. The mechanical stress effect and PVP addition on the EFV polymorphic transformation were monitored by X-ray powder diffraction, while the residual of ground EFV was collected after dissolution, analyzed by scanning electron microscopy, and provided insights into the morphological changes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154137PMC
http://dx.doi.org/10.1021/acsomega.1c00712DOI Listing

Publication Analysis

Top Keywords

efv
9
milling dissolution
8
anti-hiv drug
8
drug efavirenz
8
pvp addition
8
dissolution
7
high-energy milling
4
dissolution anti-hiv
4
drug
4
efavirenz solvents
4

Similar Publications

Virological failure is one of the main causes of failing to treat, and better management of HIV infection requires understanding and controlling the factors that contribute to this phenomenon. The main objective was to characterize the patients of the active file of the Brazzaville Outpatient Treatment Center in virological failure to identify predictive factors leading to virological failure. Conducted between June and December 2020, this was a cross-sectional study.

View Article and Find Full Text PDF

Impact of different antiretroviral therapy regimens on bone mineral density in people living with HIV: a retrospective and longitudinal study in China.

BMC Infect Dis

December 2024

Department of Infectious Disease, Beijing Ditan Hospital, Capital Medical University, No.8 Jingshun E St, Chaoyang District, Beijing, 100015, China.

Background: HIV infection and antiretroviral therapy (ART) are associated with bone loss of people living with HIV (PLWH), but limited studies exist on the impacts of ART regimens on bone mineral density (BMD) in China. This study evaluated BMD changes with three common ART regimens: tenofovir disoproxil fumarate (TDF) + lamivudine (3TC) + efavirenz (EFV), tenofovir alafenamide (TAF)-containing, and dolutegravir (DTG)-containing (non-TDF/non-TAF) therapies.

Methods: In this retrospective study, the prevalence of low BMD was analyzed in PLWH who underwent dual-energy X-ray absorptiometry (DXA) before ART initiation.

View Article and Find Full Text PDF
Article Synopsis
  • This study evaluated the prevalence of metabolic syndrome in people living with HIV who were treated with either dolutegravir (DTG) or efavirenz (EFV) from May to August 2022.
  • Among the participants, 18.6% had metabolic syndrome, with a higher prevalence of 25.6% in those on DTG compared to 11.6% on EFV.
  • Researchers found factors like higher body mass index, CD4 count, lack of physical activity, and being on a DTG regimen linked to a greater risk of metabolic syndrome, suggesting the need for lifestyle changes in DTG-treated patients.
View Article and Find Full Text PDF

Background: Ethiopia aims to eliminate mother-to-child transmission (MTCT) of HIV by 2030. In 2020, Dolutegravir-based antiretroviral treatment (ART) regimen optimization was done for the Prevention of Mother-to-Child Transmission (PMTCT). However, data tracking progress, particularly post-rollout of the Dolutegravir (DTG)-based regimen, and the real-world effectiveness of the new regimen are unavailable.

View Article and Find Full Text PDF
Article Synopsis
  • Peripartum cardiomyopathy (PPCM) poses serious health risks, and while recovery of heart function is important, it doesn't guarantee better long-term outcomes; additional assessments using cardiac MRI (CMR) can reveal further risks.
  • The study analyzed 51 PPCM patients, highlighting that lower left ventricular ejection fraction (LVEF), peak global longitudinal strain (GLS), and higher extracellular volume (ECV) were linked to worse outcomes, including the need for heart assist devices or transplants.
  • Findings suggest CMR might help identify patients at higher risk for serious adverse outcomes beyond what LVEF can indicate, potentially revealing future treatment targets like diffuse myocardial fibrosis.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!